Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  

ASSIST Program

This program provides brand name medications at no or low cost

Provided by: United Therapeutics Corporation

TEL: 877-864-8437

Languages Spoken:


Program Website


Patient Assistance Applications

ASSIST Program: Contact program


Brand Name Medications Covered

  • Adcirca tablet
  • Remodulin injection
  • Orenitram tablet; extended release
  • Tyvaso solution; inhalation

Generic Name

  • tadalafil tablet
  • treprostinil injection
  • treprostinil diolamine tablet; extended release
  • treprostinil solution; inhalation

Eligibility Requirements   

Insurance Status Determined case by case
Those with Part D Eligible? Determined case by case
Income Not disclosed
Diagnosis/Medical Criteria Not specified
US Residency Required? Must reside and receive treatment in US


Obtaining Call for prescreening
Receiving Not specified
Returning Not specified
Doctor's Action Give prescription to patient
Applicant's Action Call to enroll
Decision Communicated Not specified
Decision Timeframe Not specified


Amount/Supply Not specified
Sent To Not specified
Delivery Time Not specified
Refill Process Not specified
Limit Not specified
Re-application Not specified

Additional Information

For information on Patient Assistance Programs that may be available for United Therapeutics Corporation products (Orenitram®, Remodulin®, Tyvaso®) or Lung Biotechnology's product (Adcirca®), please contact ASSIST at 877 864-8437

Updated July 16, 2018